Status:
RECRUITING
Using AI and Peer Coaching to Address Racial Disparities Among People Who Use Opioids
Lead Sponsor:
Friends Research Institute, Inc.
Collaborating Sponsors:
Nathan Kline Institute for Psychiatric Research
NYU Langone Health
Conditions:
Opioid Use Disorder
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
Black and Latinx people who use opioids are disproportionately impacted by opioid overdose deaths. The proposed study assesses the efficacy of an open source, multimodal artificial intelligence-driven...
Detailed Description
The investigators have validated a theory-driven, artificial intelligence (AI)-driven texting tool using natural language processing to facilitate real-time text responses to patient queries combined ...
Eligibility Criteria
Inclusion
- ≥18 years of age;
- fluent in English and/or Spanish;
- self-reported non-prescription opioid use \<30 days prior to consent;
- provision of informed consent;
- planned stay in NYC ≥12 month;
- self-identified Black and/or Latinx race/ethnicity;
- positive urine toxicology for opioids per EMR records;
- diagnosis of OUD per the Diagnostic and Statistical Manual of Mental Disorders-5
- self-reported interest in initiating buprenorphine in primary care
- must have a mobile phone data plan.
Exclusion
- inability to comprehend text content written at a 3rd grade reading level;
- physical or visual disability preventing mobile phone use;
- self-reported receipt of medications for OUD in past 30 days.
Key Trial Info
Start Date :
March 28 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2026
Estimated Enrollment :
292 Patients enrolled
Trial Details
Trial ID
NCT06569667
Start Date
March 28 2025
End Date
August 31 2026
Last Update
August 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYC Health + Hospitals
The Bronx, New York, United States, 10451